Catalyst Wire Dossier Catalyst Wire Dossier

Mesothelin-CAR-T cells expressing CTLA-4 and PD-1 antibodies

· Shanghai Cell Therapy Research Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mesothelin-CAR-T cells expressing CTLA-4 and PD-1 antibodies, covering 2017-06-09 to 2017-06-09. Get the full timeline:

Most recent: Clinical Trial Update: CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor [Phase 1, Phase 2]

See pricing